Caripz 1.5mg Capsules — Cariprazine for Schizophrenia & Bipolar I
Caripz 1.5mg Capsules contain Cariprazine, a novel atypical antipsychotic that acts as a partial agonist at dopamine D3 and D2 receptors and serotonin 5-HT1A receptors. It is prescribed for schizophrenia and acute manic or mixed episodes in Bipolar I disorder in adults. Its preferential D3 receptor activity addresses both positive symptoms (hallucinations, delusions) and negative symptoms (emotional blunting, social withdrawal). Prescription required — always use under psychiatrist supervision.
Pay in 3 Installments of
Rs.
115
Caripz 1.5mg Capsules — Cariprazine for Schizophrenia & Bipolar I
Description
Caripz 1.5mg Capsules contain Cariprazine, a novel atypical antipsychotic and dopamine D3/D2 receptor partial agonist with serotonin 5-HT1A partial agonist activity. Its preferential binding to D3 receptors — which play a key role in cognition, mood regulation, and reward processing — distinguishes Cariprazine from earlier-generation antipsychotics and contributes to its efficacy in both positive and negative symptoms of schizophrenia.
Caripz 1.5mg is indicated for the treatment of adult schizophrenia (including acute and maintenance phases) and for acute manic or mixed episodes in Bipolar I disorder. By partially activating dopamine receptors rather than fully blocking them, Cariprazine helps stabilise dopaminergic tone, reducing hallucinations, delusions, disorganised thinking, and mood swings while preserving cognitive and emotional functioning. The 1.5mg dose is typically used as the starting and maintenance dose, as tolerated.
For patients requiring an increased therapeutic dose, your physician may consider Caripz 3mg Capsules. Browse our Brain Disorders collection for related neuropsychiatric therapies.
Caripz 1.5mg is a prescription-required medicine. Send a valid prescription via email: sales@derma.pk or WhatsApp: +92-320-5999650. Nationwide delivery available across Pakistan.
Usage & Benefits
- Novel D3/D2 partial agonist mechanism reduces positive and negative symptoms of schizophrenia
- Effective for acute manic and mixed episodes in Bipolar I disorder
- Preferential D3 activity supports cognitive function and emotional stability
- Lower propensity for metabolic side effects compared to many older atypical antipsychotics
- Once-daily dosing improves treatment adherence and long-term symptom management
How To Use
Use only as directed by your healthcare provider.
1. Take Caripz 1.5mg once daily at the same time each day, with or without food.
2. Swallow capsule whole with a glass of water — do not crush, chew, or open the capsule.
3. Do not stop taking Caripz suddenly without consulting your psychiatrist — abrupt discontinuation may cause relapse.
4. Report any unusual movements, restlessness (akathisia), or mood changes to your physician promptly.
5. Avoid alcohol and CNS depressants during therapy. Keep out of reach of children.
FAQs
What is Caripz 1.5mg used for?
Caripz 1.5mg contains Cariprazine and is prescribed for the treatment of schizophrenia and acute manic or mixed episodes in Bipolar I disorder in adults.
How does Cariprazine in Caripz differ from older antipsychotics?
Cariprazine is a D3/D2 partial agonist with preferential D3 binding, which addresses both positive and negative symptoms of schizophrenia and has a more favourable metabolic side effect profile compared to many older atypical antipsychotics.
Is Caripz 1.5mg a prescription medicine?
Yes — Cariprazine is always a prescription-only Rx antipsychotic. Submit a valid prescription to Derma.pk via email at sales@derma.pk or WhatsApp at +92-320-5999650 before purchase.
Dermatologist Recommended
Healer's Pharma Minoxidil 5% + Finasteride 0.25% Hair Regrowth Spray
0.25% Finasteride Topical Hair Loss Spray by Healer's Pharma
